Ribozyme-mediated trans-splicing of a trinucleotide repeat

Nature Genetics
Leonidas A PhylactouM J Wood

Abstract

Trinucleotide repeat expansions (TREs) are a recently described class of mutations characterized by a change in the size of the genomic fragment due to amplification of the repeated unit. A number of diseases have been attributed to TRE, including Huntington disease and myotonic dystrophy (DM), but attempts at genetic therapy have yet to prove successful. A potential therapeutic approach would be to repair the expanded repeat using the trans-splicing ability of group I intron ribozymes. We have used DM as a model to test this hypothesis. A group I intron ribozyme (DMPK-RZ1) was designed to modify the TRE at the 3' end of the human myotonic dystrophy protein kinase (DMPK) transcripts. DMPK-RZ1 was shown to ligate a small DMPK mRNA fragment, contained within the ribozyme, to a simple DMPK-target RNA in vitro. It also modified a larger target transcript, leading to replacement of twelve repeats with five repeats, both in vitro and in mammalian cells. Finally, this ribozyme successfully replaced the 3' end of endogenous DMPK mRNA in fibroblasts with a different 3' region. Ribozyme-mediated RNA repair may thus form a novel therapeutic strategy for diseases associated with repeat expansions.

References

Jan 1, 1992·Human Mutation·P Shelbourne, K Johnson
Mar 9, 1990·Science·N SarverJ J Rossi
Jan 1, 1990·Annual Review of Biochemistry·T R Cech
Jan 1, 1989·Cytogenetics and Cell Genetics·M KochP S Harper
Jan 20, 1984·Science·C Guerrier-Takada, S Altman
Apr 22, 1995·Lancet·M KiehntopfF Herrmann
Apr 1, 1994·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·G Bates, H Lehrach
Jun 1, 1996·Nature Medicine·J T JonesB A Sullenger
May 1, 1996·Biochemical Society Transactions·K J JohnsonN Carey
Jan 1, 1995·Annual Review of Genetics·C T Ashley, S T Warren
Sep 1, 1996·Trends in Genetics : TIG·M G Hamshere, J D Brook
Dec 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L T Timchenko, C T Caskey
Apr 1, 1997·European Journal of Biochemistry·K R BirikhF Eckstein
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·B M DavisD E Housman

❮ Previous
Next ❯

Citations

Jun 24, 2005·Biotechnology Letters·Heung-Su JungSeong-Wook Lee
Nov 8, 2003·Journal of Immunological Methods·Jacob SchlesingerGideon Gross
Apr 21, 1999·Biochimica Et Biophysica Acta·D J Gaughan, A S Whitehead
Sep 2, 1998·Trends in Genetics : TIG·J J Rossi
Nov 10, 2000·Advanced Drug Delivery Reviews·L A Phylactou
Nov 10, 2000·Advanced Drug Delivery Reviews·T Watanabe, B A Sullenger
Oct 29, 1998·Molecular Medicine Today·M W Kilpatrick, L A Phylactou
Aug 19, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Seung-Hee HongIn-Hoo Kim
Apr 27, 2007·Molecular BioSystems·Gayatri Gowrishankar, Jianghong Rao
Oct 14, 2009·Proceedings of the National Academy of Sciences of the United States of America·M Bryan WarfJ Andrew Berglund
Apr 22, 2010·Human Molecular Genetics·Susan A M MuldersDerick G Wansink
Jan 29, 2000·Nucleic Acids Research·C SchmidtS Müller
Dec 19, 2002·The Journal of Clinical Investigation·Christopher S RogersAlfred L George
Aug 5, 2003·The Journal of Clinical Investigation·Meredith B LongJonghoe Byun
Aug 5, 2003·The Journal of Clinical Investigation·Bruce A Sullenger
Jul 3, 2007·PLoS Genetics·Matthew WoodGraham McClorey
May 17, 2003·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·David SteeleGarrett A Soukup
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·B G AyreJ Haseloff
Jul 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·T Watanabe, B A Sullenger
Feb 14, 2006·FEBS Letters·Sumitaka Hasegawa, Jianghong Rao
Nov 6, 2015·Nucleic Acid Therapeutics·Chang Ho LeeSeong-Wook Lee
Mar 12, 2010·New Biotechnology·Tonje Fiskaa, Asa B Birgisdottir
Nov 13, 2009·Trends in Molecular Medicine·Florence Le RoyIsabelle Richard
Mar 16, 2007·Journal of Biotechnology·You-Sub Won, Seong-Wook Lee
May 25, 2011·Muscle & Nerve·Erin Pennock Foff, Mani S Mahadevan
Feb 18, 2011·International Journal of Cancer. Journal International Du Cancer·Guyee BanSeong-Wook Lee
Mar 22, 2016·ACS Synthetic Biology·Manish KushwahaAlfonso Jaramillo
Jan 8, 2000·Dermatologic Clinics·M T LinJ Uitto
Dec 9, 2003·Journal of Biochemistry and Molecular Biology·Kyung-Ju Ryu, Seong-Wook Lee
Apr 17, 2003·FEMS Microbiology Reviews·Elena Puerta-FernándezAlfredo Berzal-Herranz
Oct 15, 2014·Journal of Biotechnology·Sung Jin Kim, Seong-Wook Lee
Sep 27, 2014·Drug Discovery Today·Bruno M D C GodinhoJohn F Cryan
Sep 2, 2006·Biochemical and Biophysical Research Communications·Heung-Su Jung, Seong-Wook Lee
Jul 26, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Byung-Su KwonSeong-Wook Lee
Apr 2, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kyung-Ju RyuSeong-Wook Lee
Aug 6, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kyung-Sook ShinSeong-Wook Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.